COMP <GO>
RDGT vs PETS // REVENUE GROWTH (YOY)
Ridgetech Inc. (NASDAQ) VS. PetMed Express Inc. (NASDAQ) • 15-METRIC TALLY: RDGT 4
— PETS 4
▲ REVENUE GROWTH (YOY) LEADER: RDGT
LAST: $0.80 (-3.32%) • MKT CAP: $3.0M
revenue-growth
10.20%
LAST: $1.19 (+0.85%) • MKT CAP: $25.6M
revenue-growth
-21.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDGT VS. PETS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RDGT | PETS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.60% | 28.10% | -24.50 | PETS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -1.40% | -32.80% | +31.40 | RDGT | /operating-margins <GO> |
| Net Profit Margin | -0.90% | -32.00% | +31.10 | RDGT | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 10.20% | -21.10% | +31.30 | RDGT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.08% | -0.08 | PETS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.24 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | PETS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.0 | 33.1 | +13.90 | RDGT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.0M | $25.6M | -$22.6M | PETS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RDGT REV | PETS REV | RDGT GROSS % | PETS GROSS % | RDGT FCF | PETS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $132.2M | $179.0M | 3.6% | 28.1% | -$1.4M | -$33.0M |
| FY 2024 | $120.0M | $227.0M | 3.2% | 30.5% | $1.1M | -$395.0K |
| FY 2023 | $124.0M | $274.1M | — | — | -$3.2M | $4.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RDGT // BETA —
PETS // BETA —